title: Cellular entry via an actin and clathrin-dependent route is required for Lv2 restriction of HIV-2.
abstract: Lv2 is a human factor that restricts infection of some HIV-2 viruses after entry into particular target cells. HIV-2 MCR is highly susceptible to Lv2 whereas HIV-2 MCN is not. The block is after reverse transcription but prior to nuclear entry. The viral determinants for this restriction have been mapped to the HIV-2 envelope and the capsid genes. Our model of Lv2 restriction suggests that the route taken into a cell is important in determining whether a productive infection occurs. Here we characterised the infectious routes used by MCN and MCR using chemical compounds and molecular techniques to distinguish between potential pathways. Our results suggest that susceptible MCR can enter restrictive HeLa(CD4) cells via two pathways; a clathrin/AP2 mediated endocytic route that is sensitive to Lv2 restriction and an alternative, non-clathrin mediated route, which results in more efficient infection.
authors.affiliation: Queen Mary, University of London, Whitechapel, London, UK. ian.harrison@medsch.ucl.ac.uk
authors.forename: I P
authors.initials: IP
authors.lastname: Harrison
authors.forename: A
authors.initials: A
authors.lastname: McKnight
mesh_terms: D000199:Actins / Q000378:metabolism*; D033962:Adaptor Protein Complex 2 / Q000378:metabolism; D015153:Blotting, Western; D045744:Cell Line, Tumor; D002966:Clathrin / Q000378:metabolism*; D004705:Endocytosis / Q000187:drug effects; D015686:Gene Products, env / Q000235:genetics / Q000378:metabolism; D015498:HIV-2 / Q000235:genetics / Q000502:physiology*; D006367:HeLa Cells; D006801:Humans; D008563:Membrane Lipids / Q000235:genetics; D009154:Mutation; D034741:RNA, Small Interfering; D014759:Viral Envelope Proteins / Q000187:drug effects / Q000235:genetics; D053586:Virus Internalization / Q000187:drug effects*
chemical_list: D000199:Actins; D033962:Adaptor Protein Complex 2; D002966:Clathrin; D015686:Gene Products, env; D008563:Membrane Lipids; D034741:RNA, Small Interfering; D014759:Viral Envelope Proteins; C050629:viral envelope lipids